People
The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 12 members and is chaired by Dr. Daniel Vasella.
Download the Novartis organizational structure (20 KB)
Board of Directors
Daniel Vasella, M.D.
Chairman
Read biography:
Ulrich Lehner, Ph.D.
Vice Chairman
Read biography:
Hans-Joerg Rudloff
Vice Chairman
Read biography:
William Brody, M.D., Ph.D.
Read biography:
Srikant Datar, Ph.D.
Read biography:
Ann Fudge
Read biography:
Alexandre F. Jetzer
Read biography:
Pierre Landolt
Read biography:
Andreas von Planta, Ph.D.
Read biography:
Dr. Ing. Wendelin Wiedeking
Read biography:
Marjorie Mun Tak Yang
Read biography:
Rolf M. Zinkernagel, M.D.
Read biography:
Corporate Secretary
Monika Matti
Read biography:
Corporate governance
We are fully committed to good corporate governance.
Company history
Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz.
Our businesses
We offer a wide range of healthcare products in pharmaceuticals, vaccines and diagnostics, generics and consumer health.
